Abstracts

• Introduction

  Meletios Dimopoulos

  https://doi.org/10.4081/hmr.v2i14.507

  164

  PDF: 130

  • PDF

• Improving treatment outcomes by understanding cytogenetics in myelodysplastic

  Aristotle Giagounidis

  https://doi.org/10.4081/hmr.v2i14.508

  186

  PDF: 349

  • PDF

• Transfusion independence and cytogenetic response in myelodysplastic syndromes. What this means for the patient

  Alan F. List

  https://doi.org/10.4081/hmr.v2i14.509

  203

  PDF: 554

  • PDF

• Prolonging time to progression and survival in relapsed/refractory multiple myeloma

  Pieter Sonneveld

  https://doi.org/10.4081/hmr.v2i14.510

  223

  PDF: 422

  • PDF

• Targeting the microenvironment: a new treatment paradigm for chronic lymphocytic leukaemia

  Asher Chanan-Khan

  https://doi.org/10.4081/hmr.v2i14.511

  182

  PDF: 465

  • PDF